BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38905847)

  • 1. Immunogenic cell death inducers for cancer therapy: An emerging focus on natural products.
    Zhang LL; Zhang DJ; Shi JX; Huang MY; Yu JM; Chen XJ; Wei X; Zou L; Lu JJ
    Phytomedicine; 2024 Jun; 132():155828. PubMed ID: 38905847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural Compounds of Marine Origin as Inducers of Immunogenic Cell Death (ICD): Potential Role for Cancer Interception and Therapy.
    Sansone C; Bruno A; Piscitelli C; Baci D; Fontana A; Brunet C; Noonan DM; Albini A
    Cells; 2021 Jan; 10(2):. PubMed ID: 33504012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulators of immunogenic cell death for cancer therapy: focusing on natural compounds.
    Amiri M; Molavi O; Sabetkam S; Jafari S; Montazersaheb S
    Cancer Cell Int; 2023 Sep; 23(1):200. PubMed ID: 37705051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research progress in inducing immunogenic cell death of tumor cells.
    Xie D; Wang Q; Wu G
    Front Immunol; 2022; 13():1017400. PubMed ID: 36466838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural compound inducers of immunogenic cell death.
    Diederich M
    Arch Pharm Res; 2019 Jul; 42(7):629-645. PubMed ID: 30955159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoring the Immunity in the Tumor Microenvironment: Insights into Immunogenic Cell Death in Onco-Therapies.
    Hernández ÁP; Juanes-Velasco P; Landeira-Viñuela A; Bareke H; Montalvillo E; Góngora R; Fuentes M
    Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34198850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenic cell death in cancer therapy: Present and emerging inducers.
    Zhou J; Wang G; Chen Y; Wang H; Hua Y; Cai Z
    J Cell Mol Med; 2019 Aug; 23(8):4854-4865. PubMed ID: 31210425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering nanomedicines for immunogenic eradication of cancer cells: Recent trends and synergistic approaches.
    Elzoghby AO; Samir O; Emam HE; Soliman A; Abdelgalil RM; Elmorshedy YM; Elkhodairy KA; Nasr ML
    Acta Pharm Sin B; 2024 Jun; 14(6):2475-2504. PubMed ID: 38828160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromomycin A
    Florêncio KGD; Edson EA; Fernandes KSDS; Luiz JPM; Pinto FDCL; Pessoa ODL; Cunha FQ; Machado-Neto JA; Wilke DV
    Front Immunol; 2022; 13():941757. PubMed ID: 36439184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mecheliolide elicits ROS-mediated ERS driven immunogenic cell death in hepatocellular carcinoma.
    Xu Z; Xu J; Sun S; Lin W; Li Y; Lu Q; Li F; Yang Z; Lu Y; Liu W
    Redox Biol; 2022 Aug; 54():102351. PubMed ID: 35671636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The copper (II) complex of salicylate phenanthroline induces immunogenic cell death of colorectal cancer cells through inducing endoplasmic reticulum stress.
    Chen M; Wang D; Fan L; Niu D; Xu J; Liu Y; Liu Y
    Int Immunopharmacol; 2024 May; 132():111980. PubMed ID: 38555819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenic cell death-based cancer vaccines: promising prospect in cancer therapy.
    Wang J; Ma J; Xie F; Miao F; Lv L; Huang Y; Zhang X; Yu J; Tai Z; Zhu Q; Bao L
    Front Immunol; 2024; 15():1389173. PubMed ID: 38745666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reinforcing the immunogenic cell death to enhance cancer immunotherapy efficacy.
    Yu S; Xiao H; Ma L; Zhang J; Zhang J
    Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188946. PubMed ID: 37385565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer.
    Huang L; Rong Y; Tang X; Yi K; Qi P; Hou J; Liu W; He Y; Gao X; Yuan C; Wang F
    Mol Cancer; 2022 Feb; 21(1):45. PubMed ID: 35148751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of unfolded protein response-associated miRNAs in immunogenic cell death amplification: A literature review and bioinformatics analysis.
    Azizi M; Salehi-Mazandarani S; Nikpour P; Andalib A; Rezaei M
    Life Sci; 2023 Feb; 314():121341. PubMed ID: 36586572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Damage-Associated Molecular Patterns Modulation by microRNA: Relevance on Immunogenic Cell Death and Cancer Treatment Outcome.
    Lamberti MJ; Nigro A; Casolaro V; Rumie Vittar NB; Dal Col J
    Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34073766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenic Cell Death Role in Urothelial Cancer Therapy.
    Yadollahvandmiandoab R; Jalalizadeh M; Buosi K; Garcia-Perdomo HA; Reis LO
    Curr Oncol; 2022 Sep; 29(9):6700-6713. PubMed ID: 36135095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitize Tumor Immunotherapy: Immunogenic Cell Death Inducing Nanosystems.
    Peng J; Li S; Ti H
    Int J Nanomedicine; 2024; 19():5895-5930. PubMed ID: 38895146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical application of immunogenic cell death inducers in cancer immunotherapy: turning cold tumors hot.
    Han Y; Tian X; Zhai J; Zhang Z
    Front Cell Dev Biol; 2024; 12():1363121. PubMed ID: 38774648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rafoxanide Induces Immunogenic Death of Colorectal Cancer Cells.
    Di Grazia A; Laudisi F; Di Fusco D; Franzè E; Ortenzi A; Monteleone I; Monteleone G; Stolfi C
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32455811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.